Developmental toxicity assessment of arsenic acid in mice and rabbits

Reproductive Toxicology

Volumn 12, Issue 6, 1998, Pages 647-658

  Nemec, Mark D ^a   Holson, Joseph F ^a   Farr, Craig H ^b   Hood, Ronald D ^c  

^a WIL RESEARCH LABORATORIES   (United States)

^b Elf Atochem North America Inc   (United States)

^c UNIVERSITY OF ALABAMA   (United States)

Author keywords

Arsenate; Arsenic; Arsenic acid; Developmental toxicity; Mouse; NOAEL; Rabbit

Indexed keywords

ARSENIC ACID; ARSENIC ACID DERIVATIVE; TERATOGENIC AGENT;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS DEVELOPMENT; FETUS MALFORMATION; FETUS WEIGHT; MOUSE; NONHUMAN; ORGANOGENESIS; PREGNANCY; PRENATAL MORTALITY; RABBIT; REPRODUCTIVE TOXICITY; SURVIVAL RATE;

ANIMALS; ARSENATES; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; MATERNAL-FETAL EXCHANGE; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PREGNANCY; RABBITS; SURVIVAL RATE; TERATOGENS;

EID: 0032215929     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(98)00053-7     Document Type: Article

References (54)

1. Fishbein L. Sources, transport, and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect. 40:1981;43-64.
2. Borum D.R., Abernathy C.O. Human oral exposure to inorganic arsenic. Arsenic, Exposure and Health Special Issue of Environ Geochem Health. 16:1994;21-30.
3. Cantor K.P. Arsenic in drinking water: how much is too much? Epidemiology. 7:1996;113-115.
4. Hood R.D. Cacodylic acid: agricultural uses, biologic effects, and environmental fate. 1985;Veterans Administration Central Office, Department of Medicine and Surgery, Agent Orange Projects Office, Washington, DC. (Available from Superintendent of Documents, U.S. Government Printing Office, Washington, DC).
5. Toxicological profile for arsenic. 1993;99 U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
6. Carlson-Lynch H., Beck B.D., Boardman P.D. Arsenic risk assessment. Environ Health Perspect. 102:1994;354-356.
7. Hughes K., Meek M.E., Newhook R., Chan P.K.L. Speciation in health risk assessments of metals: evaluation of effects associated with forms present in the environment. Regulat Toxicol Pharmacol. 22:1995;213-220.
8. Anke M. Arsenic. Mertz W. Trace elements in human and animal nutrition. vol. 2:1986;347-371 Academic Press, San Diego.
9. Arsenic. National Research Council, Safe Drinking Water Committee. Drinking water and health. 1983;National Academy Press, Washington, DC.
10. O'Connor T.P. Campbell T.C. Essentiality of the trace element arsenic. Final Report. Carcinogen Assessment Group, Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, unpublished. Available from U.S. EPA Headquarters Library, Washington, DC; 1985.
11. EPA. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. Washington, DC: Risk Assessment Forum, U.S. Environmental Protection Agency, EPA/625/3-87-013; July 1988.
12. Uthus E.O. Arsenic essentiality and factors affecting its importance. Arsenic, exposure and health. Special Issue of Environ Geochem Health. 16:1994;199-208.
13. Hood R.D., Bishop S.L. Teratogenic effects of sodium arsenate in mice. Arch Environ Health. 24:1972;62-65.
14. Hood R.D. Effects of sodium arsenite on fetal development. Bull Environ Contam Toxicol. 7:1972;216-222.
15. Domingo J.L., Gómez M., Sánchez D.J., Llobet J.M. Effects of monoisoamyl meso-2,3-dimercaptosuccinate on arsenite-induced maternal and developmental toxicity in mice. Res Commun Molec Pathol Pharmacol. 89:1995;389-400.
16. Beaudoin A.R. Teratogenicity of sodium arsenate in rats. Teratology. 10:1974;153-158.
17. Burk D., Beaudoin A.R. Arsenate-induced renal agenesis in rats. Teratology. 16:1977;247-260.
18. Ferm V.H., Carpenter S.J. Malformations induced by sodium arsenate. J Reprod Fertil. 17:1968;199-201.
19. Hood R.D., Harrison W.P. Effects of prenatal arsenite exposure in the hamster. Bull Environ Contam Toxicol. 29:1982;671-678.
20. Matsumoto N., Okino T., Katsunuma H., Iijima S. Effects of Na-arsenite on the growth and development of the foetal mice. Congen Anom Current Lit. 13:1973;175-176.
21. Hood R.D., Thacker G.T., Patterson B.L., Szczech G.M. Prenatal effects of oral vs. ip sodium arsenate in mice. J Environ Pathol Toxicol. 1:1978;857-864.
22. Baxley M.N., Hood R.D., Vedel G.C., Harrison W.P., Szczech G.M. Prenatal toxicity of orally administered sodium arsenite in mice. Bull Environ Contam Toxicol. 26:1981;749-756.
23. Kojima H. Studies on developmental pharmacology of arsenite. 2. Effects of arsenite on pregnancy, nutrition, and hard tissue. Folia Pharmacol Japon. 70:1974;149-163.
24. Two-generation dietary reproduction study with arsenic acid in mice. 1990;Hazleton Laboratories America, Inc, Study No. HLA 6120-138. Vienna, VA. (unpublished study report).
25. Hood R.D., Vedel G.C., Zaworotko M.J., Tatum F.M. Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. J Toxicol Environ Health. 25:1988;423-434.
26. Hood R.D., Vedel-Macrander G.C., Zaworotko M.J., Tatum F.M., Meeks R.G. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or ip administration. Teratology. 35:1987;19-25.
27. Woolson E.A. Fate of arsenicals in different environmental substrates. Environ Health Perspect. 19:1977;73-81.
28. Nemec M.D. A teratology study in mice with arsenic acid (75%), Project No. WIL-75028. 1988;WIL Research Laboratories, Ashland, OH. (unpublished study report).
29. Nemec M.D. A teratology study in rabbits with arsenic acid (75%), Project No. WIL-75026. 1988;WIL Research Laboratories, Ashland, OH. (unpublished study report).
30. U.S. Environmental Protection Agency. Pesticide assessment guidelines, subdivision F, hazard evaluation: humans and domestic animals. Washington, DC: Environmental Protection Agency: 540/9-82-025; 1982. Available from NTIS, Springfield, VA.
31. Sved D.W., Dahlgren R.R. Oversight regulations. Chengelis C.P., Holson J.F., Gad S.C. In Regulatory Toxicology . 1995;211-228 Raven Press, New York.
32. U.S. Environmental Protection Agency. Good laboratory practice standards for health effects. Environmental Protection Agency, Fed Reg; 1979;44:27362.
33. Mann S., Droz P.O., Vahter M. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol Appl Pharmacol. 137:1996;8-22.
34. 2 (Staining method for macroscopic evidence of implantation sites in the rat uterus.). Naunyn Schmiedbergs Arch Exp Pathol Pharmakol. 247:1964;367.
35. Wilson J.G. Embryological considerations in teratology. Wilson J.G., Warkany J. Teratology principles and techniques . 1965;251-261 University of Chicago Press, Chicago.
36. Woo D.C., Hoar R.M. "Apparent hydronephrosis" as a normal aspect of renal development in late gestation of rats: the effect of methyl salicylate. Teratology. 6:1972;191-196.
37. Stuckhardt J.L., Poppe S.M. Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing. Teratogen Carcinogen Mutagen. 4:1984;181-188.
38. Dawson A.B. A note on the staining of the skeletons of cleared specimens with alizarin red S. Stain Technol. 1:1926;123-124.
39. Dixon W.J., Brown M.D. Biomedical computer programs. 1979;780-781 University of California Press, Berkeley, CA.
40. Steel R.G.D., Torrie J.H. Principles and procedures of statistics, 2nd ed. 1980;McGraw-Hill, New York.
41. Hood R.D. Tests for developmental toxicity. Hood R.D. Developmental toxicology - risk assessment and the future. 1990;155-175 Van Nostrand Reinhold, New York.
42. Tyl R.W., Marr M.C. Developmental toxicity testing - methodology. Hood R.D. Handbook of developmental toxicology. 1997;175-225 CRC Press, Boca Raton, FL.
43. Rao K.S., Schwetz B.A., Park C.N. Reproductive toxicity risk assessment of chemicals. Vet Hum Toxicol. 23:1981;167-175.
44. Brent R.L. Evaluating the alleged teratogenicity of environmental agents. Clin Perinatol. 13:1986;609-613.
45. Chernoff G.F. Developmental risk assessments. Koren G. Maternal-fetal toxicology. 1994;15-31 Marcel Dekker, New York.
46. Environmental Protection Agency. Guidelines for developmental toxicity risk assessment; Notice. Federal Register. 1991;56:63798-63826.
47. Shepard T.H. Catalog of teratogenic agents. 1992;xiii-xvi Johns Hopkins University Press, Baltimore.
48. Palmer A.K. Use of mammalian models in teratology. Marois M. Prevention of physical and mental congenital defects, Part A: the scope of the problem. Progress in clinical and biological research, vol. 163A. 1985;97-106 Alan R. Liss, New York.
49. Palmer A.K. The relevance of minor structural differences. Teratology. 38:1988;6A.
50. Perraud J. Levels of spontaneous malformations in the CD rat and the CD-1 mouse. Lab Animal Sci. 26:1976;293-300.
51. Palmer A.K. Incidence of sporadic malformations, anomalies, and variations in random-bred laboratory animals. Neubert D., Merker H.-J., Kwasigroch T.E. Methods in prenatal toxicology: evaluation of embryotoxic effects in experimental animals. 1977;52-70 Georg Thieme, Stuttgart.
52. Historical control data. Hood R.D. Handbook of developmental toxicology. 1997;713-733 CRC Press, Boca Raton, FL.
53. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem Biol Interactions. 47:1983;29-44.
54. Nelson C.J., Holson J.F., Gaines T.B., et al. Developmental toxicity of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T). II. Multireplicated dose-response studies with technical and analytical grades of 2,4,5-T in four-way outcross mice. Fund Appl Toxicol. 19:1992;298-306.